NAKA Nakamoto Inc climbs 378 percent on investor optimism despite weak Q4 2025 earnings and steep YoY revenue decline CNTA Centessa earnings miss widens as loss per share reaches 048 concerns grow over pipeline costs FBRX Forte Biosciences Inc reports wider than expected Q4 2025 loss with shares falling 352 following the earnings release BIAFW bioAffinity reports quarterly results with no revenue or earnings data disclosed investors await further details